PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
19295274-0	2009	[Preoperative therapy using trastuzumab and weekly paclitaxel in a stage IIIB inoperable locally advanced HER2- positive breast cancer with complete pathologic response].	Paclitaxel	51-61	erb-b2 receptor tyrosine kinase 2	Homo sapiens	106-110	
19295274-6	2009	We conclude that the combination of weekly paclitaxel and trastuzumab is a promising neoadjuvant therapy regimen for HER2 positive, ER-negative breast cancer.	Paclitaxel	43-53	erb-b2 receptor tyrosine kinase 2	Homo sapiens	117-121